Development of ROBUST-RCT: Risk Of Bias instrument for Use in SysTematic reviews-for Randomised Controlled Trials
Ying Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Gordon Guyatt(Impact), Paul Glasziou(Bond University), Matthias Briel(University Hospital of Basel), Dena Zeraatkar(Impact), Elie A. Akl(American University of Beirut Medical Center), Sheri A. Keitz(Miami VA Healthcare System), Philippe Ravaud(Inserm), Kenneth F. Schulz(University of North Carolina at Chapel Hill), Dirk Bassler(University of Zurich), Reed Siemieniuk(Impact), Jane L. Hutton(University of Warwick), Susan Armijo‐Olivo(University of Alberta), David Torgerson(University of York), Romina Brignardello-Petersen(Impact), Carrol Gamble(University of Liverpool), Lise Lotte Gluud(University of Copenhagen), Luz María Letelier S(Pontificia Universidad Católica de Chile)
Cited by 45
Related Papers
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
|Arthritis & Rheumatology|2015|2.8k
Prevention of VTE in Nonsurgical Patients
|CHEST Journal|2012|2.7k
The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure.
|PubMed|1985|2.1k
Interpretation of the evidence for the efficacy and safety of statin therapy
|The Lancet|2016|1.8k